Intensity Therapeutics Price to Book Ratio

Intensity Therapeutics (INTS) currently reports a P/B ratio of 1.17. That is below the sector sector average of 7.46. Use the charts on this page to explore Intensity Therapeutics's P/B ratio history and peer comparisons.

Intensity Therapeutics's P/B ratio of 1.17 is lower than the its sector sector average of 7.46. That is roughly 84.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/B ratio is a valuation multiple that relates Intensity Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 1.17, INTS can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/B ratio of 1.17, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 7.46. From there, open related valuation or income-statement pages for Intensity Therapeutics, and consider following INTS for alerts when major investors trade the stock.